EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis

Sang-Hyup Lee, Yong-Joon Lee, Jung Ho Heo, Seung-Ho Hur, Hyun Hee Choi, Kyung-Jin Kim, Ju Han Kim, Keun-Ho Park, Jung Hee Lee, Yu Jeong Choi, Seung-Jun Lee, Sung-Jin Hong und 7 weitere

Journal of the American College of Cardiology · 2023

DOI: 10.1016/j.jacc.2023.02.007 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American College of Cardiology, 2023. Verfasst von Sang-Hyup Lee und 18 weiteren Autor:innen. Beteiligte Einrichtung: Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Anticholesteremic Agents, Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Yonsei University College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The routine use of high-intensity statins should be considered carefully in elderly patients because of their higher risk of intolerance or adverse events. OBJECTIVES: We evaluated the impact of moderate-intensity statin with ezetimibe combination therapy compared with high-intensity statin monotherapy in elderly patients with atherosclerotic cardiovascular disease (ASCVD). METHODS: In this post hoc analysis of the RACING (RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases) trial, patients were stratified by age (≥75 years and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsAnticholesteremic AgentsCardiovascular DiseasesAtherosclerosisAgedHumansEzetimibeDrug Therapy, CombinationLipidsTreatment Outcome

Stichwörter der Autor:innen

atherosclerotic cardiovascular diseaseelderlyezetimibestatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsEzetimibeAnticholesteremic AgentsLipids

Autor:innen und Institutionen

  • Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kosin University Gospel Hospital, Busan, Korea. Electronic address: duggymdc@gmail.com.
  • Keimyung University Dongsan Medical Center, Daegu, Korea.
  • Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea.
  • Ewha Womans University Mokdong Hospital, Seoul, Korea.
  • Chonnam National University Hospital, Gwangju, Korea.

Förderung

  • Yonsei University College of Medicine

Zitieren

APA

Lee, S. H., Lee, Y. J., Heo, J. H., Hur, S. H., Choi, H. H., Kim, K. J., Kim, J. H., Park, K. H., Lee, J. H., Choi, Y. J., Lee, S. J., Hong, S. J., Ahn, C. M., Kim, B. K., Ko, Y. G., Choi, D., Hong, M. K., Jang, Y., & Kim, J. S. (2023). Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2023.02.007

Vancouver

Lee SH, Lee YJ, Heo JH, Hur SH, Choi HH, Kim KJ, et al. Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis. Journal of the American College of Cardiology. 2023. doi:10.1016/j.jacc.2023.02.007

BibTeX
@article{Lee2023,
  author = {Lee, Sang-Hyup and Lee, Yong-Joon and Heo, Jung Ho and Hur, Seung-Ho and Choi, Hyun Hee and Kim, Kyung-Jin and Kim, Ju Han and Park, Keun-Ho and Lee, Jung Hee and Choi, Yu Jeong and Lee, Seung-Jun and Hong, Sung-Jin and Ahn, Chul-Min and Kim, Byeong-Keuk and Ko, Young-Guk and Choi, Donghoon and Hong, Myeong-Ki and Jang, Yangsoo and Kim, Jung-Sun},
  title = {Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis},
  journal = {Journal of the American College of Cardiology},
  year = {2023},
  doi = {10.1016/j.jacc.2023.02.007}
}
Kostenlos starten →